- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT01493544
Prevalence Study and Regular Practice Among General Practitioners in Populations at Risk of Chronic Obstructive Pulmonary Disease (COPD) in Latin America (PUMA PROJECT)
Prevalence Study and Regular Practice (Diagnosis and Treatment) Among General Practitioners in Populations at Risk of COPD in Latin America
Studie Overzicht
Toestand
Conditie
Gedetailleerde beschrijving
Studietype
Inschrijving (Werkelijk)
Contacten en locaties
Studie Locaties
-
-
-
Capital Federal, Argentinië
- Research Site
-
-
Buenos Aires
-
Escobar, Buenos Aires, Argentinië
- Research Site
-
Ezeiza, Buenos Aires, Argentinië
- Research Site
-
Los Polvorines, Buenos Aires, Argentinië
- Research Site
-
Martinez, Buenos Aires, Argentinië
- Research Site
-
Quilmes, Buenos Aires, Argentinië
- Research Site
-
Ramos Mejia, Buenos Aires, Argentinië
- Research Site
-
-
-
-
Antioquia
-
Medellin, Antioquia, Colombia
- Research Site
-
-
Atlantico
-
Barranquilla, Atlantico, Colombia
- Research Site
-
-
Caldas
-
Manizales, Caldas, Colombia
- Research Site
-
-
Quindio
-
Armenia, Quindio, Colombia
- Research Site
-
-
Valle Del Cauca
-
Cali, Valle Del Cauca, Colombia
- Research Site
-
-
-
-
-
Montevideo, Uruguay
- Research Site
-
-
-
-
-
Barquisimeto, Venezuela
- Research Site
-
Caracas, Venezuela
- Research Site
-
Maracaibo, Venezuela
- Research Site
-
Porlamar, Venezuela
- Research Site
-
Valencia, Venezuela
- Research Site
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
Beschrijving
Inclusion Criteria:
- Men or women aged more or equal than 40
- Current or former smokers and/or patients exposed to biomass combustion:
Cigarettes: more or equal than 10 packs/year; Pipes: more or equal than 50 pipes/year; Cigars: more or equal than 50 cigars/year; Combustion: more or equal 100 hours/firewood/year
Exclusion Criteria:
- Pregnancy
- Patients with contraindications for spirometry
- Physical or mental disability rendering the patient unable to undergo a spirometry test and to contribute data to the study
- Heart rate ≥ 120 beats by minute
- Patients currently undergoing treatment for tuberculosis
- A patient who is participating in an interventional clinical trial or was previously included in this study
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Number of participants with an affirmative response to specific categories on the PUMA questionnaire.
Tijdsspanne: Baseline
|
PUMA Questionnaire: Based on the PLATINO questionnaire.
Applied to patients to describe different aspects potentially related to Chronic Obstructive Pulmonary Disease (COPD) such as: respiratory symptoms, smoking, respiratory medication, health care resources usage, comorbidieties, etc., as well as the registration of procedures (spirometry and oximetry) carried out and anthropometric data.
|
Baseline
|
FEV1 spirometry measures.
Tijdsspanne: Baseline and visit 2 up to 4 weeks after baseline (if applicable)
|
FEV1 is the volume of air expelled from the lungs in 1 second. The second visit will be scheduled only for those patients who do not meet criteria for deferring spirometry. |
Baseline and visit 2 up to 4 weeks after baseline (if applicable)
|
SaO2 (Arterial Oxygen Saturation) - pulse oximetry.
Tijdsspanne: Baseline and visit 2 up to 4 weeks after baseline (if applicable)
|
The second visit will be scheduled only for those patients who do not meet criteria for deferring spirometry.
|
Baseline and visit 2 up to 4 weeks after baseline (if applicable)
|
Number of participants with an affirmative response to specific categories on the Medical History Questionnaire (if applicable).
Tijdsspanne: Baseline
|
Questionnaire based on the patient's personal medical history at the site.
Its application will be subject to the existence of a prior medical history for the patient at site.
If the patient has no prior medical history at site, then this questionnaire will not apply.
|
Baseline
|
FEV1/FVC spirometry measures.
Tijdsspanne: Baseline and visit 2 up to 4 weeks after baseline (if applicable)
|
Ratio of Forced Expiratory Volume in 1 second (volume of air expelled from the lungs in 1 second) by the Forced Vital Capacity (FVC, the volume of air that can forcibly be blown out after full inspiration) is a spirometric measure (lung function test) used to demonstrate airway obstruction. The second visit will be scheduled only for those patients who do not meet criteria for deferring spirometry. |
Baseline and visit 2 up to 4 weeks after baseline (if applicable)
|
Heart rate (HR) - pulse oximetry.
Tijdsspanne: Baseline and visit 2 up to 4 weeks after baseline (if applicable)
|
The second visit will be scheduled only for those patients who do not meet criteria for deferring spirometry.
|
Baseline and visit 2 up to 4 weeks after baseline (if applicable)
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Studie stoel: Maria Montes de Oca, Internist - Pulmonologist, Universidad Central de Venezuela
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Schatting)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- NIS-RLA-XXX-2011/1
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .